StockNews.com assumed coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research note published on Thursday. The firm issued a hold rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Stock Up 16.7 %
Shares of Sorrento Therapeutics stock opened at $0.01 on Thursday. The business’s fifty day simple moving average is $0.01 and its 200-day simple moving average is $0.04. Sorrento Therapeutics has a 52 week low of $0.00 and a 52 week high of $0.42.
Sorrento Therapeutics Company Profile
Further Reading
- Five stocks we like better than Sorrento Therapeutics
- What is a buyback in stocks? A comprehensive guide for investors
- MarketBeat Week in Review – 5/20 – 5/24
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- NASDAQ 100 vs. NASDAQ Composite: A Detailed Breakdown of NASDAQ
- Where to Find Earnings Call Transcripts
- These 2 Retail Traders Favorites are Nearing Major Breakouts
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.